Supplemental Financial Information (Tables)

12 Months Ended

Dec. 31, 2025

Balance Sheet Related Disclosures [Abstract]

Schedule of Property, Plant and Equipment Net

Property, plant and equipment, net consisted of the following (in thousands):


		December 31, 2025				December 31, 2024
Leasehold improvements		$	2,152			$	2,117
Laboratory equipment			3,306				3,130
Computer equipment			749				707
Furniture and fixtures			921				864
Construction in progress			4,292				4,251
			11,420				11,069
Accumulated depreciation			(4,684	)			(3,584	)
Property, plant and equipment, net		$	6,736			$	7,485

Schedule of Accrued Expenses and Other Current Labilities

Accrued expenses and other current liabilities consisted of the following (in thousands):


		December 31, 2025				December 31, 2024
Accrued compensation		$	9,425			$	5,242
Accrued research and development			3,591				1,714
Accrued clinical trial			3,290				1,907
Lease liabilities, current portion			1,865				1,877
Warrant liability			—				438
Accrued professional and consulting fees			1,310				725
Accrued property, plant and equipment			19				207
Other			777				752
Total accrued expenses and other current liabilities		$	20,277			$	12,862

Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):


		December 31, 2025				December 31, 2024
Prepaid research and development		$	2,460			$	841
Prepaid clinical trial			866				1,112
Deferred offering costs			195				135
Prepaid insurance			108				249
Other			802				308
Total prepaid expenses and other current assets		$	4,431			$	2,645